LKFTのPER（株価収益率）は？

Lakefront Biotherapeutics NV（LKFT）は現在PER 2.24倍で取引されています。

LKFTのROE（自己資本利益率）は？

Lakefront Biotherapeutics NVのROEは15.02%です。

LKFTの配当利回りは？

Lakefront Biotherapeutics NVの配当利回りは0.00%です。

LKFTの品質スコア（Quality Score）は？

当社のAIはLKFTの総合財務品質を100点中85点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

LKFTは今が買い時ですか？

当社AIのタイミングスコアは100点中26点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

LKFTはどのセクターに属しますか？

Lakefront Biotherapeutics NVはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

LKFT (NASDAQ) 株価分析 | LAKEFRONT BIOTHERAPEUTICS NV

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-03 | FS: 2026-03-31)

LKFT AI Analysis Summary

Our AI summary for LKFT: Lakefront Biotherapeutics NV (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 2.24, ROE of 15.02%, a dividend yield of 0.00%. Its financial Quality Score stands at 85/100 — fundamentals stronger than most of the market. The AI Timing Score is 26/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

LKFT

Lakefront Biotherapeutics NV

US:NASDAQ STOCK Healthcare >> Biotechnology

USD 26.74

-0.29 (-1.08%) Day Change

Watchlist Portfolio Compare Chart

2.24

P/E

0.00

D/E

15.0%

ROE

14.5%

ROA

0.00%

Div Yield

0.09

PEG

LAKEFRONT BIOTHERAPEUTICS NV
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 26.74 Price -0.29 (-1.08%) Day Change	NEWS SCORE: N/A

LKFT, ファンダメンタルスコアはvery good ( ファンダメンタル = 85) but テクニカルスコアは ...(Sign In to See)...

Loading chart...

85 QUALITY

Signal: OUTPERFORM

Signal Description: Company financial health is Good

Reason: 平均ROEが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are ok , financial health is not good , and ability to make profit is ok , ...

Deepscope 分析

63%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.12 From 30 days period
News Score	N/A
Magic Formula Rank by ROA	167
Magic Formula Rank by ROE	167
Magic Formula Rank by ROIC	64 GOOD
Price	26.74
PBV / Sector	0.55 / 44,219.29 GREAT
Earning Per Share	7.34

PE / Sector	2.24 / 19.28 GREAT
PEG or PE/Growth / Sector	0.09 / 1.23 GREAT
Average 1M Daily Value	4.97 M GREAT
Average 1W Daily Value	6.14 M

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

68%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	46.83 / 98.22 GREAT
NPM Average (%) / Sector	20.10 / -1,697.63 GREAT
NPM Change Average (%) / Sector	-49.41 / 5,097.97
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	14.49 / 185,260.96
ROA Average (%) / Sector	5.19 / 36,684.70
ROA Change Average (%) / Sector	52.77 / 422,221.66 GREAT
ROE (%) / Sector	15.02 / 243,762.23
ROE Average (%) / Sector	5.29 / 48,758.47
ROE Change Average (%) / Sector	21.33 / 424,968.10 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.19

登録情報

Analyze Date	2026-08-04 08:01:48
Symbol	LKFT
Name	LAKEFRONT BIOTHERAPEUTICS NV
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	65.48 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	1,781.84 / 9,645.64

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: SchaliEnhoevedreef 20 T, Mechelen, Belgium, 2800

Phone: 32 1 534 29 00

Website: https://lakefrontbio.com

Employees: 452

Sector: Healthcare >> Biotechnology

Description: Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in a phase 1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc. The company was formerly known as Galapagos NV and changed its name to Lakefront Biotherapeutics NV in May 2026. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium.